ADA 2025 20 - 23 June 2025

Effect of Type 2 Diabetes Characteristics on Semaglutide Treatment in People with Type 2 Diabetes and Peripheral Artery Disease: A Post-Hoc Analysis of the STRIDE Trial

Authors :

Neda Rasouli¹; Ecenur G. Arslan²; Andrei-Mircea Catarig²; Kim Houlind^3,4; Bernhard Ludvik⁵; Joakim Nordanstig⁶; Harald Sourij⁷; Sebastian Thomas⁸; Subodh Verma⁹; Marc P. Bonaca¹⁰;

Affiliations

View Details Hide Details

Keywords

Cardiovascular Disease

Congress oral presentation

GLP-1 RA

Semaglutide

PHASE 3 (RCT)

Search Science Hub

Are you a healthcare professional?

Effect of Type 2 Diabetes Characteristics on Semaglutide Treatment in People with Type 2 Diabetes and Peripheral Artery Disease: A Post-Hoc Analysis of the STRIDE Trial